In addition, the alignment with the ␣/␤-hydrolase fold region indicated that PhaG belongs to ␣/␤-hydrolase superfamily. Accordingly, CD analysis suggested a secondary structure composition of 29% ␣؊helix, 22% ␤-sheet, 18% ␤-turn, and 31% random coil. Site-specific mutagenesis of seven highly conserved amino acid residues (Asp-60, Ser-102, His-177, Asp-182, His-192, Asp-223, His-251) was used to validate the protein model and to investigate organization of the transacylase active site. Only the D182(A/E) mutation was permissive with about 30% specific activity of the wild type enzyme. Furthermore, this mutation caused a change in substrate specificity, indicating a functional role in substrate binding. The serine-specific agent phenylmethylsulfonyl fluoride (PMSF) or the histidinespecific agent diethylpyrocarbonate (DEPC) caused inhibition of 3-hydroxyacyl transfer to holo-ACP, and the S102(A/T) or H251(A/R) PhaG mutant was incapable of catalyzing 3-hydroxyacyl transfer, suggesting that these residues are part of a catalytic triad.
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thioester to CoA, has not been described for any other type of transacylase. PhaG Pp directly links the fatty acid de novo biosynthesis with the polyester (polyhydroxyalkanoate, PHA) biosynthesis by the provision of the activated precursor (R)-3-hydroxyacyl-CoA (Fig. 1) . Meanwhile, these transacylases have also been found in other pseudomonads, which are capable of synthesizing medium-chain length polyester from non-related carbon sources (2) (3) (4) . So far these enzymes have only been identified in bacteria belonging to pseudomonads also considering ongoing genome sequencing projects. The transacylasemediated biosynthesis pathway has been already established in bacteria, which are not capable of accumulating polyester, by co-expression of a PHA synthase gene with the phaG gene (5, 6) . PhaG exhibits a key enzyme activity in polyester production from non-related carbon sources, i.e. when the fatty acid de novo biosynthesis provides precursor and thus provides an important tool to establish this pathway in biotechnologically relevant organisms (6) . In the primary structure of the transacylase, an HX 4 D motif has been identified, which is conserved among glycosyltransferases (1) . However, in the active transacylase found in Pseudomonas sp. 61-3 the Asp residue was replaced by a Leu residue, which indicated that this motif might not be required for enzyme activity. Meanwhile, nine phaG genes have been identified in nine Pseudomonas species, and four of the genes were functionally assigned (1) (2) (3) (4) . Interestingly, these transacylases share a rather high homology ranging from 75-98% similarity.
The aims of this study were: (i) the purification of the transacylase from P. putida at high yield, (ii) the establishment of a new enzyme assay, (iii) the enzymological and biochemical characterization of the enzyme, and (iv) the investigation of the catalytic mechanism.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, and Cultivation Conditions-All bacteria and plasmids investigated in this study are listed in Table I . Cultivations were performed in Luria Bertani Broth (LB) or M9 medium containing the indicated carbon source, supplements, and antibiotics. Organic * This study was supported by Grant Re 1097/4-1 from the Deutsche Forschungsgemeinschaft (to B. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Both authors contributed equally to this study. ʈ To whom correspondence should be addressed. Tel.: 49-251-8339848; Fax: 49-251-8338388; E-mail: rehm@uni-muenster.de. acids were provided as sodium salts. Cultivations were conducted at 37 and 30°C employing E. coli or P. putida, respectively, either with 50 ml of medium in 300-ml Erlenmeyer flasks that were agitated on a shaker at 200 rpm.
Isolation, Manipulation, and Mutagenesis of DNA-All genetic techniques were performed as described by Sambrook et al. (10) . Sitespecific mutagenesis of the various amino acid residues in the P. putida transacylase and the hexahistidine tag fusions of the transacylase were obtained employing overlapping PCR (11) and pBHR81 containing the 1-kb EcoRI-BamHI fragment comprising the phaG gene from P. putida as template DNA (1) . All oligonucleotides are summarized in Table I . Site-specific mutagenesis was conducted to replace seven amino acid residues, which were conserved among transacylases from pseudomonads. Mutagenized PCR products as well as PCR products encoding a C-or N-terminal His 6 tag were subcloned into EcoRI/BamHI sites of plasmid pBBR1MCS-2 (8) directly downstream of the lac promoter in order to monitor the in vivo activity of the respective transacylase. For the construction of phaG-overexpressing plasmids, the coding region of the phaG gene from P. putida was amplified by tailored PCR introducing restriction sites for NdeI and BamHI at the 5Ј-and 3Ј-end, respectively. The resulting PCR product was inserted into the corresponding restriction sites of vector pT7-7, resulting in plasmid pAM1, under the control of T7 RNA polymerase promoter Ø10. E. coli BL21(DE3) was used to overexpress the gene encoding the His 6 -tagged fusion protein.
Isolation and Purification of Inclusion Bodies-Cells were dissolved in 50 mM phosphate buffer, pH 8.0, containing lysozyme and DNase I and incubated on ice for 30 min. Then EDTA was added to a final concentration of 10 mM, and the cells were incubated on ice for another 20 min. After French press treatment, the crude extract was centrifuged at 10,000 ϫ g for 20 min to obtain the insoluble fraction. The resulting sediment was suspended in 50 mM phosphate buffer, pH 8.0, containing 0.15 M NaCl and 1 mM EDTA. After incubation on ice for 20 min, the inclusion bodies were sedimented as described above. The inclusion bodies were washed in phosphate buffer containing 2 M urea and 0.5% Triton X-100. Finally the purified inclusion bodies were dissolved in phosphate buffer containing 6 M guanidine HCl and 3 mM 2-mercaptoethanol. The guanidium HCl insoluble materials were removed by centrifugation at 10,000 ϫ g for 10 min.
Purification and Refolding of PhaG-The dissolved and denatured protein was subjected to metal chelate affinity chromatography using a Ni 2ϩ -NTA acid resin (Qiagen, Germany) with a bed volume of 5 ml. Equilibration was performed according to the manufacturer's protocol on an FPLC apparatus (Amersham Biosciences) with 50 mM phosphate buffer, pH 8.0, containing 300 mM NaCl, 8 M urea, 1 mM 2-mercaptoethanol, and 10% glycerol. After washing at pH 6.3, the denatured His-tagged PhaG was eluted at pH 4.3. Refolding was achieved by applying purified and denatured His-tagged PhaG, whose concentration was adjusted to 50 g/ml to gel filtration chromatography using Sephadex G25. This column was equilibrated with 20 mM phosphate buffer, pH 8.0, and the refolded active enzyme was obtained after elution.
Purification of His 6 -PhaG under Native Conditions-His 6 -PhaG was purified under native conditions using native PAGE as previously described (1) . Analytical Gel Filtration Chromatography-The native molecular mass of the refolded PhaG was estimated by gel filtration chromatography on Superdex 200 HR 10/30 column (10 ϫ 300 mm) equilibrated with 50 mM sodium phosphate buffer (pH 7.0) containing 0.15 M NaCl and at a flow rate of 1 ml/min. The analyzed protein sample was directly taken from the refolding experiment, applying 4 ml with about 30 g/ml protein concentration. Protein in the eluate was monitored at A 280 ; fractions were collected and analyzed by SDS-PAGE. For calibration, standard proteins (Amersham Biosciences) were chromatographed under the same conditions. Dynamic Light Scattering (DLS)-All light scattering experiments were performed with a DynaPro molecular sizing instrument (Protein Solutions) at a fixed angle of 90°. The Dynamics 5.25.44 software package was used for data analysis. The translational diffusion coefficient (D T ) of the sample particles was determined by measuring the fluctuations in the intensity of scattered light with an autocorrelation function. The hydrodynamic radius (R h ) of the particles was calculated by the Stokes-Einstein equation (D T ϭ k B T/6R h , with k B referring to Boltzmann's constant, T to the absolute temperature, and to the solvent viscosity). Assuming that the particles are spherical and of standard density, the molecular mass of the particles was estimated from R h . The autocorrelation function was analyzed using a bimodal exponential cumulant analysis procedure. The polydispersity parameter and the error distribution function provided evidence of the homogeneity of the particle size in the solution. Before the DLS experiments all protein solutions were filtered using a 0.02-m filter (Anodisc 13; Whatman). DLS of refolded transacylase was measured at 25°C and at a concentration of 0.55 mg ml Ϫ1 in 10 mM sodium phosphate buffer (pH 8.0); 50 independent measurements were accumulated for each sample, and the values reported are the mean values.
Circular Dichroism Spectroscopy-CD spectra were recorded on a Jobin-Yvon (Paris) spectropolarimeter, model CD 6Ј, equipped with a self constructed cuvette holder whose temperature is controlled by a Peltier element. Measurements were performed in 10 mM sodium borate buffer (pH 9.0) or 10 mM sodium phosphate buffer (pH 8.0). The spectra were recorded at 20°C. The protein concentrations used ranged from 390 to 590 g/ml. A cuvette of 0.1-mm path length was used. The results were expressed as mean residue ellipticity, [⌰] MRE ϭ (MRW⅐ obs / c⅐d), where obs is the observed ellipticity, MRW is the mean residue weight of PhaG fusion protein (106,72 Da), d is the cuvette path length, and c is the specific protein concentration. Deconvolution of CD spectra was done using the program CDNN of Bohm et al. (12) .
SDS PAGE and Western Immunoblotting-SDS-PAGE was performed according to Sambrook et al. (10) . Proteins were separated in 12.5 (w/v) % SDS-polyacrylamide gels and stained with Coomassie Brilliant Blue R-250. Western blotting was performed using the Semidry Fastblott (Biometra, Germany). On Western blots (13) using nitrocellulose membranes the PHA synthase and its mutants were detected applying the respective monospecific, polyclonal anti-PhaG antiserum raised against the PhaG from P. putida and an alkaline-phosphatase- 
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C terminus antibody conjugate as second antibody. Bound antibodies were detected using the luminogenic substrate CDP-Star (Amersham Biosciences) and exposure to x-ray film.
In Vivo Activity of the Transacylase-In vivo activity of the respective transacylase was obtained by complementation of phaG-negative mutant P. putida PhaG N -21 (1). Recombinant cells harboring the respective plasmid were cultivated in MM medium plus 1.5% (w/v) sodium gluconate, and after 48 h incubation at 30°C the PHA content of lyophilized cells was determined by GC analysis. PHA accumulation from gluconate indicated in vivo activity of PhaG. The activity of modified transacylases was obtained relative to the wild type transacylase activity, i.e. as the amount of accumulated PHA mediated by the wild type enzyme.
In Vitro Activity of the Transacylase-PhaG activity was determined spectrophotometrically by monitoring the release of CoA using the thiol reagent 5,5Ј-dithionitrobenzoic acid (DTNB) and measuring the change in absorbance at 412 nm. The standard assay contained 3 mM MgCl 2 , 40 M of the respective CoA thioester and 20 M holo-ACP in 50 mM Tris/HCl, pH 7.5, at 30°C in a total volume of 100 l. Kinetic studies were performed by removing aliquots (10 l) from the reaction mixture at timed intervals, and the reaction was stopped by addition of 50% (w/v) trichloroacetic acid (30 l) and 10 mg/ml BSA (30 l). BSA was added as a carrier (30 l, 10 mg/ml), and the protein (PhaG and ACP) was allowed to precipitate on ice for 15 min and then pelleted by centrifugation. Released CoA was spectrophotometrically determined employing the thiol reagent DTNB as previously described (1) . One unit of enzyme has been defined as the amount which produced 1 mol of acyl-ACP (1 mol of released CoA) per minute under the assay conditions employed. All assays were repeated in triplicate, and appropriate control experiments were routinely performed.
Inhibition Studies Using PMSF-His 6 -PhaG (1 mM) was incubated in 50 mM phosphate buffer (pH 7.5) for 60 min at 30°C with 0, 0.1, 1, and 2 mM PMSF in a total volume of 100 l. Aliquots were removed to determine the CoA release as described above. To assess the ability of 3-hydroxydecanoyl-CoA to protect the enzyme from inhibition, 1 mM His 6 -PhaG was incubated for 5 min at 30°C with 100 and 500 M 3-hydroxydecanoyl-CoA, respectively. The aliquots were diluted to volumes of 20 l by addition of PMSF in buffer to the appropriate concentrations, and the inhibition experiments were repeated.
Inhibition Studies Using DEPC-For inhibition studies, 1 mM purified PhaG was incubated at 30°C in 40 mM potassium phosphate, pH 7.5, with various concentrations of the histidine reagent DEPC (Sigma) for 60 min. DEPC solutions (in ethanol) were made each day just prior to an experiment. Exact DEPC concentrations were determined by reacting with an excess of imidazole (Sigma) and measuring the A 240 (⑀ ϭ 3200 M Ϫ1 ) (14) . DEPC reactions with PhaG at 30°C were quenched by a 1:50 dilution into 10 mM imidazole (on ice) (at least a 10-fold molar excess over the DEPC). DEPC, ethanol, and imidazole at the concentrations used have no effect on the substrates of the PhaG reaction, and ethanol and imidazole have no effect on PhaG activity at the levels at which they are carried over into the assay mixture (not shown). The PhaG/DEPC/imidazole mixtures were further diluted with 1 mg/ml BSA and assayed by the standard method as described above. For substrate protection studies, 1 mM purified PhaG was incubated at 30°C for 5 min in 40 mM potassium phosphate, pH 7.5, and 2 mM DEPC in the presence of 100 and 500 M 3-hydroxydecanoyl-CoA. The reactions were quenched by a 1:50 dilution into 10 mM imidazole. The mixtures were then further diluted as appropriate into 1 mg/ml BSA and assayed by the standard method as described above.
Gas Chromatographic/Mass Spectrometry Analysis of Polyester in Cells-PHA was qualitatively and quantitatively analyzed by gas chromatography/mass spectrometry (GC/MS). Liquid cultures were centrifuged at 10,000 ϫ g for 15 min, then the cells were washed twice in saline and lyophilized overnight. 8 -10 mg lyophilized cell material was subjected to methanolysis in the presence of 15% (v/v) sulfuric acid. The resulting methyl esters of the constituent 3-hydroxyalkanoic acids were assayed by GC/MS according to Brandl et al. (15) and as described in detail previously (16) . GC/MS analysis was performed by injecting 3 l of sample into a PerkinElmer 8420 gas chromatograph (Ü berlingen, Germany) using a 0.5-m-diameter Permphase PEG 25 Mx capillary column 60 m in length.
Analysis of (R,S)-3-Hydroxydecanoyl-CoA-The substrate (R,S)-3-hydroxydecanoyl-CoA was synthesized as previously described (1) . (R,S)-3-hydroxydecanoyl-CoA was purified using Sep-Pak cartridges (reversed-phase C 18 column, Waters) and eluting the CoA thioester with 0.01 N NaOH in 20% (v/v) methanol. The purified (R,S)-3-hydroxydecanoyl-CoA was analyzed by HPLC, and its concentration was determined by hydroxylamine treatment, which causes a release of bound CoA. The concentration of free CoA before and after hydroxylamine treatment (17) 
Subcellular Localization of PhaG in P.
putida-Since various enzymes involved in PHA biosynthesis are localized at the PHA-granule surface, we investigated the subcellular localization of PhaG in P. putida. Therefore, P. putida cells were cultivated under PHA accumulation conditions employing nitrogen-starvation and gluconate as sole carbon source. The soluble cytosolic fraction and the insoluble envelope/PHA-granule fraction were obtained by ultracentrifugation of crude extracts. PhaG was only detected in the soluble cytosolic fraction by immunoblotting applying monospecific anti-PhaG-antibodies raised against PhaG from P. putida (Fig. 2) .
Overproduction of PhaG-The expression of the transacylase gene phaG under control of the lac promoter was weak and resulted only in a PhaG production of about 5% total protein (1) . In this study, we have subcloned the P. putida phaG into the E. coli expression vector pT7-7 as described under "Experimental Procedures," allowing PhaG to be overproduced as a His 6 -tagged protein with phaG under Ø10 promoter control. Since, the N-terminal His tag fusion showed only 6.8% of wild type activity and the C-terminal His tag fusion exhibited 91% of wild type activity, the C-terminal His 6 tag fusion was overproduced (Table II) . The respective plasmid pAM1, which contained the coding region encoding the His 6 tag fusion protein collinear to the Ø10 promoter in restriction sites NdeI and BamHI, was transferred into E. coli BL21(DE3) and, upon induction of the T7 RNA polymerase gene with 1 mM isopropylthio-␤-D-galactoside, overproduction of the His 6 tag fusion protein was observed, amounting to about 80% of the total protein (Fig. 3) . The His 6 tag fusion protein occurred as inactive inclusion bodies. This was concluded from microscopic observations of light-scattering inclusions in cells as well as from the isolated insoluble fusion protein. No in vivo activity of the overproduced fusion protein was obtained, which was concluded from the absence of PHA accumulation in recombinant E. coli as described previously (6) . For the test gluconate was provided as carbon source, and the fatty acid de novo biosynthesis was inhibited with triclosan, in order to provide substrates for class II PHA synthases mediated by PhaG. Enzymatic activity correlates with the accumulation of PHA, which can be determined by GC/MS analysis. Cells overproducing the fusion protein did not show any accumulation of PHA. Moreover, no in vitro enzymatic activity was detected.
Purification of PhaG from Inclusion Bodies-Inclusion bodies from E. coli BL21(DE3) harboring pAA1 of a 100-ml culture were isolated and purified as described under "Experimental Procedures." After the final washing of the inclusion bodies a purity of transacylase fusion protein of about 80% was obtained (Fig. 3) . E. coli crude extracts containing the inclusion bodies and purified inclusion bodies were each subjected separately to in vitro enzymatic activity analysis using (R,S)-3-hydroxydecanoyl-CoA as substrate and holo-ACP as acceptor, but no enzymatic activity was detected, respectively. The purified inclusion bodies were dissolved in 6 M guanidium-HCl and 3 mM 2-mercaptoethanol. The denatured PhaG fusion protein was then purified to electrophoretic homogeneity by metal chelate affinity chromatography and was refolded by gel filtration chromatography as described under "Experimental Procedures." The PhaG-containing fraction was collected and subjected to SDS-PAGE analysis. SDS-PAGE analysis showed that the PhaG fusion protein was purified to homogeneity (Fig. 3) . The purified and refolded His 6 tag PhaG was analyzed for in vitro enzyme activity. A specific enzyme activity of 12.4 milliunits/mg protein was determined using (R)-3-hydroxydecanoylCoA as substrate.
CD Spectroscopy of Transacylase-In order to provide further evidence for proper refolding of the transacylase fusion protein, CD spectroscopy was employed. Both native and refolded protein, purified as described above, was used for the measurements. To allow comparison of the secondary structure content of the native, refolded and denatured protein, CD spectra of all three species were recorded under the same buffer conditions. The CD spectra of native and refolded protein are evidently similar at pH 9.0 and 20°C (Fig. 4) . The spectra of both purified native and refolded protein show characteristic minima at 208 and 222 nm, indicative of ␣-helical structure. However, the absolute MRE values suggest a relatively low ␣-helical content. Therefore other conformational motifs such as ␤-sheets and coiled elements appear to determine the structure. This interpretation is supported by the deconvolution of the spectra, which resulted in the following secondary structure composition: 28% ␣-helices, 24% ␤-sheet, 18.5% ␤-turn, and 30% random coil. The spectrum of the denatured protein at 95°C shows the typical random coil ellipticity.
When decreasing the pH from 9.0 to 8.0 at 25°C a significant change toward negative MRE values is observed. This is indicative of a more native-like structure at a pH value closer to physiological conditions.
Analysis of the Molecular Weight of the Refolded His 6 -PhaG-
In order to analyze the molecular weight of the active and refolded His 6 -PhaG from P. putida, we performed gel filtration chromatography as well as light-scattering analysis. His 6 -PhaG obtained after refolding at a protein concentration of about 0.1 mg/ml was directly subjected to gel filtration chromatography applying Superdex 200. A single peak was obtained, which indicated an apparent molecular weight of 33,080, while the exact molecular weight of the His 6 -tagged PhaG is 34,737 (Fig. 5) . In the presence of the substrate (R)-3-hydroxydecanoyl-CoA additional peaks were observed corresponding to apparent molecular weights of 45.4, 83.7, and 102, respectively (Fig. 5) . The refolded His 6 -PhaG was concentrated by 10-fold applying ultrafiltration and resulting in a protein concentration of about 1 mg/ml. This sample was subjected to dynamic light scattering analysis, which indicated a molecular weight of about 68 (Fig. 6) .
Establishment of an in Vitro Transacylase Assay-Purified and refolded His 6 -PhaG was first assayed qualitatively for its ability to catalyze the transfer of 3-hydroxydecanoyl from 3-hydroxydecanoyl-CoA to E. coli holo-ACP, using HPLC analysis as previously described (1) . A new enzyme assay was established allowing determination of PhaG activity spectrophotometrically by monitoring the release of CoA at 412 nm. Released CoA was spectrophotometrically determined employing the thiol reagent DTNB. The holo-ACP, whose thiol group would interfere with the detection of CoA, was removed by trichloroacetic acid precipitation. Kinetic studies were performed by removing aliquots (10 l) from the reaction mixture at timed intervals as described under "Experimental Procedures."
Kinetic Analysis of PhaG-The turnover of 3-hydroxydecanoyl-CoA catalysed by PhaG was monitored as a function of time. The reaction was started applying E. coli holo-ACP. No lag phase was observed, and about 80% of the 3-hydroxydecanoyl-CoA was converted to 3-hydroxydecanoyl-ACP (Fig. 7) . The formation of 3-hydroxydecanoyl-ACP was confirmed by HPLC analysis as previously described (1). The enzyme activity was recorded as a function of 3-hydroxydecanoyl-CoA and 3-hydroxydecanoyl-ACP concentration, respectively. A sigmoidal curve was obtained in both experiments, which could be represented as a Hill plot indicating that the transacylase behaves as an allosteric enzyme (Fig. 8) . The Hill plot analysis revealed Hill coefficients of 1.32 and 1.38 for (R)-3-hydroxydecanoyl-CoA and holo-ACP, respectively, which indicated positive substrate cooperativity. K 0.5 values of 65 M and 28 M for (R)-3-hydroxydecanoyl-CoA and holo-ACP, respectively, were also obtained from Hill plot analysis. A V max of 12.4 milliunits/mg and 11.7 milliunits/mg with (R)-3-hydroxydecanoyl-CoA and holo-ACP, respectively, was estimated from Lineweaver-Burk plot analysis considering substrate concentrations of Ͼ15 M.
Development of a Threading Model of the P. putida Transacylase-A PSI-Blast search in combination with a conserved domain alignment showed about 30% similarity of PhaG with the epoxide hydrolase (1cqz) from mouse and about 22% identity with conserved ␣/␤-hydrolase fold region (Fig. 9) . These alignments were used to generate a threading model of PhaG (residues 7-285) including two small deletions (22-24, 260 -262) . Deletions were introduced, because no homology of these regions to structurally conserved regions was found, and the loop search against a loop fold library failed (Homology (software package), Molecular Simulations). However, deletions were located in variable regions according to the multiple alignment of transacylases (Fig. 10) . A threading model of PhaG was finally CoA release was monitored in a discontinuous assay using DTNB (Ellman, 1959) . The transacylase was applied at a concentration of 10 g/ml.
FIG. 8. In vitro activity of His 6 -tagged PhaG employing various concentrations of (R)-3-hydroxydecanoyl-CoA (A) and holo-ACP (B).
The transacylase was applied at a concentration of 10 g/ml. Data are presented as Hill plots. developed using software packages Homology and Discover (Molecular Simulations) (Fig. 11) . Energy minimization was performed employing the consistent valence force field (CVFF) implemented in DISCOVER. The stereochemistry of the model structure was evaluated with the program PROCHECK (19) , and the residue environment was analyzed with the VERIFY_3D program that implements the algorithm of Lü thy et al. (20) . The resulting model suggests that PhaG is a member of the superfamily of the ␣/␤-hydrolases possessing a conserved ␣/␤-hydrolase fold as the core structure. Additional submission of the PhaG sequence to three other algorithm that search structural databases (SAM-T98, Ref. 21; 3D-PSSM, Ref. 22 ; and the UCLA Foldserver, Ref. 23 ) resulted in fits to other enzymes belonging to the ␣/␤-hydrolase fold family with high confidence levels (data not shown). Inspection of the protein model of PhaG showed that a putative active site Ser-102, a conserved His-251, and the Asp-223, presumably forming a catalytic triad, are adjacent to the core structure (Fig. 11) . These residues are conserved in all transacylases. The putative active site Ser-102 was located at the nucleophile elbow, a sharp ␥ turn containing the nucleophilic residue, positioned between a ␤-strand and an ␣-helix, which is one of the most conserved features of the ␣/␤-hydrolase enzymes. Moreover, Ser-102 is located in a "lipase-box (GXSXG)"-like pentapeptide SFSWG.
Active Site Residues-We probed the active site of P. putida PhaG by incubating it with the hydroxyl-specific agent PMSF. Preincubation of His 6 -PhaG with PMSF caused significant inhibition (Table III) . However, preincubation in the presence of the substrate, 3-hydroxydecanoyl-CoA, reduced the level of inhibition, indicating the likelihood of a nucleophilic hydroxyl at the active site. Furthermore, the histidine reagent DEPC was used to study the role of histidines in enzyme activity. Incubation of purified His 6 -PhaG with DEPC, a histidine reagent, causes inhibition of enzymatic activity (Table III) . His 6 -PhaG is stable under the preincubation conditions in the absence of DEPC. The inhibition of activity depends upon the concentration of DEPC. To determine whether the inactivation of His 6 -PhaG results from modification of an active site residue, we looked for substrate protection against DEPC inactivation. The substrate 3-hydroxydecanoyl-CoA protects His 6 -PhaG from inactivation by DEPC (Table III) . Holo-ACP itself contains one histidine residue, and consequently care was taken to ensure that holo-ACP was not simply scavenging the DEPC reagent. Protection by 3-hydroxyacyl-CoA suggests that the modified residue accounting for the inactivation is in the P. putida PhaG active site or at least in the cleft which docks 3-hydroxyacyl-CoA.
Mutational Analysis of the P. putida PhaG-With the aid of the multiple PhaG sequence alignment (ClustalW), we depicted seven amino acid residues (Asp-60, Ser-102, His-177, Asp-182, FIG. 9 . Alignment of the Pseudomonas putida transacylase PhaG with the mouse epoxide hydrolase (1cqz) (A) and the conserved ␣/␤-hydrolase fold region (B). The alignment was performed using PSI-Blast and the conserved domain (CD) search, respectively. Conservative replacements are labeled with a light gray background, and identical residues are labeled with dark gray background. Mutagenized residues are labeled with asterisks. The putative lipase-box is underlined or boxed.
His-192, Asp-223, His-251), which might be involved in enzyme activity. Except Asp-182, all of these residues were conserved among the transacylases and residues Ser-102, Asp-223, and His-251 were also conserved in the ␣/␤-hydrolase fold region (RPS-Blast in the conserved domain data base) by forming the catalytic triad. Residues His-177 and Asp-182 were depicted to investigate the role of the HX 4 D motif. The following mutations of PhaG were performed considering conservative and nonconservative replacements and using site-specific mutagenesis: D60(E/A), S102(T/A), H177(R/A), D182(E/A), H192(R/A), D223(E/A), H251(R/A) (Figs. 9 -11 ). All mutants were analyzed with respect to in vivo and in vitro enzyme activity as described under "Experimental Procedures." For in vitro activity analysis of the modified transacylases, the enzymes were purified by refolding from inclusion bodies, which would also indicate folding deficiencies caused by the respective mutations. However, only the site-specific mutants D182E and D182A, respectively, were permissive and showed in vivo and in vitro transacylase activity (Table IV) . In vivo activity was achieved by expression of the respective mutated transacylase gene via plasmids (Table I) derived from vector pBBR1MCS-2 in the transacylasenegative mutant P. putida PHAG N -21 and by quantitative analysis of the accumulated PHA (Table IV) . Furthermore, the composition of the accumulated PHA mediated by these modified transacylases (D182E or D182A), respectively, was significantly shifted toward a higher molar fraction of (R)-3-hydroxydodecanoate (Table IV) . Interestingly, the residue Asp-182, whose replacement was permissive, was the only investigated amino acid residue position, which was located at the protein model surface (Fig. 11) .
Kinetic Analysis of Wild Type and Mutant PhaG Enzymes-To quantify the impact of the D182E and D182A mutations on the catalytic activity of the P. putida PhaG, the steady-state kinetic parameters of the wild type enzyme and the single mutants were measured as described under "Experimental Procedures." In the presence of holo-ACP as the acceptor thiol, the estimated V max value of the two mutants was about 40% less, respectively, when compared with the wild type enzyme, which was consistent with reduced in vivo activity (Table IV) .
DISCUSSION
In this study, we performed for the first time the biochemical and enzymological characterization of an (R)-3-hydroxyacyl-ACP:CoA transacylase. The transacylase from P. putida was obtained at high yield by heterologous overexpression of the transacylase gene phaG in E. coli. Only, the C-terminal His 6 tag fusion resulted in an active enzyme, whereas the N-terminal His 6 tag fusion did strongly impair enzyme activity (Table  II) . This was consistent with a rather conserved N terminus and a less conserved C terminus of PhaG, which indicated a functional role of the N terminus of the enzyme (Fig. 10) . Active enzyme was quantitatively obtained from inclusion bodies employing the C-terminal His 6 tag fusion of PhaG and Ni 2ϩ - nitrilitriacetic acid-agarose affinity chromatography under denaturing conditions followed by refolding during gel filtration chromatography, which describes a new strategy for efficient refolding (Fig. 3) . CD analysis confirmed the proper refolding of His 6 -PhaG (Fig. 4) .
The deconvolution of the CD data resulted in a prediction of the secondary structure of ϳ29% ␣-helix, 22% ␤-sheet, 18% ␤-turn, and 31% random coil. This value is consistent with the threading model developed for PhaG in this study, which is based on structural similarities to an epoxide hydrolase belonging to the ␣/␤-hydrolase superfamily. The determination of the molecular weight of the refolded His 6 -tagged PhaG indicated that at low PhaG concentrations the monomer is present, whereas at higher PhaG concentrations, as required for dynamic light scattering analysis, evidence for a dimeric organization was found (Figs. 5 and 6) . The autocorrelation function shown in Fig. 6 can only be fitted using a bimodal function. The bimodal fitting procedure identifies two species of significantly different hydrodynamic radius. One is obviously water (R H ϭ 0.11 nm). The second species is found to be the protein with a hydrodynamic radius of 3.39 nm and a molecular mass of 68 kDa, when assuming validity of the Stokes Einstein equation. The mass is slightly higher than that of a dimer of the transacylase (67.8 kDa). Assuming an equilibrium constant of dimerization in the range of 6Ÿ 10 4 liter mol Ϫ1 to 4Ÿ 10 5 liter mol Ϫ1 the monomer would not be detectable in our instrument as its concentration is below the minimal concentration of 0.215 mg ml Ϫ1 required for a reliable signal. The dimer on the other hand would not be detectible in gel filtration chromatography as its concentration would be below 5 g ml Ϫ1 at the applied total protein concentration of 50 g ml Ϫ1 . This explanation provides a rationale for the different molar masses observed by gel filtration and DLS. Moreover, in the presence of the substrate (R)-3-hydroxyacyl-CoA the transacylase appeared in apparent molecular weights of 45.4, 83.7 and 102, which indicated substrate-induced conformational changes and oligomerization of the transacylase (Fig. 5) . A new enzyme assay was established for the transacylase, which implemented the thiol reagent DTNB for monitoring of released CoA and which allowed the first kinetic analysis of PhaG (Fig. 7) . The enzymological characterization of the transacylase showed that the 3-hydroxyacyl transfer to holo-ACP, catalyzed by His 6 -PhaG, gave K 0.5 values of 28 M (ACP) and 65 M (3-hydroxyacyl-CoA) considering V max values of 11.7 milliunits/mg and 12.4 milliunits/mg, respectively. A Hill coefficient of 1.38 (ACP) and 1.32 (3-hydroxyacyl-CoA) indicated a positive substrate cooperativity (Fig. 8) , which is consistent with substrate-induced conformational changes observed by gel filtration chromatography (Fig. 5) .
All known acyl transferases involved in fatty acid and polyketide biosynthesis are homologous. Mutational, biochemical, and structural studies have established the centrality of two universally conserved residues: a serine residue (corresponding to Ser-102 in the P. putida transacylase) and a histidine residue (corresponding to His-255 in the P. putida transacylase). The catalytic cycle of acyl transferases, such as e.g. the malonyl-CoA:ACP transacylase involves a ping-pong mechanism in which an acyl group is first transferred from a CoA thioester onto the serine residue, followed by transesterification of this acyl group onto the pantetheine arm of an ACP (24) . Consistent with this prediction, x-ray crystallographic analysis of the malonyl-CoA:ACP transacylase from the E. coli fatty acid synthase revealed that the conserved serine and histidine residues lie in the active site of the enzyme and are hydrogen bonded in a fashion similar to various serine hydrolases (25) . Finally, mutagenesis of acyl transferase domains in modular polyketide synthases (26) and fatty acid synthase systems (27) has confirmed the requirement of this serine for acyl transferase activity. The PhaG transacylases, however, appear to catalyze a similar reaction by transferring a 3-hydroxyacyl moiety from the holo-ACP thioester to CoA. Interestingly, these transacylases exhibit only weak homology of about 10% identity to the acyl transferases. In this study, we were guided by the strong similarity between primary amino acid sequences of various members of this family of proteins (Fig.  10) as well as to ␣/␤-hydrolases (Figs. 9 and 10) . The multiple alignments indicated that eighteen amino acid residues are conserved among the transacylases and ␣/␤-hydrolases. More- A, the threading model of PhaG from Pseudomonas putida. The threading model was developed based on the alignment shown in Fig. 9 . The software packages Homology and Discover (Molecular Simulations) were applied to generate the model. Cylinders represent ␣-helical structures. Large arrows in dark gray represent ␤-strands. The putative catalytic residues were given as stick side chains or CPK models and indicated by arrows. B, localization of the single amino acid residue replacements in the PhaG model. Amino acid residue replacements were achieved by site-specific mutagenesis (see Table IV ). Only the backbone of the PhaG model is shown. The replacing side chains are given as CPK format. C, the spatial arrangement of the functionally analyzed amino acid residues was given by representing the respective side chains in stick format. over all transacylases share a putative lipase box (SX[S]XG) in which the first G residue of the lipase is replaced by a serine in the transacylase. In this study, we developed a threading model of the (R)-3-hydroxyacyl-ACP:CoA transacylase from P. putida based on the homology to the mouse epoxide hydrolase (1cqz), whose structure has been determined by x-ray analysis (28) . Many of the features of the ␣/␤-hydrolase fold are maintained in the protein model. The central ␤-sheet in the core of the molecule conforms to the ␣/␤-hydrolase fold (Fig. 11) . Moreover, deconvolution of CD spectra predicted a secondary structure composition of PhaG also found in enzymes belonging to the superfamily of ␣/␤-hydrolases. Inspection of the proposed PhaG model showed that the residues Ser-102, His-251, and Asp-223 are located adjacent to the core structure of PhaG protein model and forming a catalytic triad with the putative catalytic Ser-102 located at the nucleophile elbow (Fig. 11) . This putative active-site Ser-102 lies at the C-terminal end of a ␤-strand, corresponding to strand ␤5 of the lipases, in the strand-turnhelix motif. These three residues were replaced by site-directed mutagenesis, which abolished transacylase activity, indicating an essential role of these residues in enzyme catalysis. However, site-directed mutagenesis of the amino acid residues Asp-60 and His-192, respectively, which are conserved among the transacylases and which might also play a role in constitution of the catalytic triad, resulted also in inactivation of the enzyme. These residues, which are required for enzyme catalysis, are also located in the core structure of the PhaG model (Fig. 11 ). Inhibition studies with serine-and histidine-specific inhibitors indicated that Ser-102 and one of the essential histidine residues is involved in enzymatic activity (Table III) . The conserved His-177 and the non-conserved Asp-182, which constitute the putative HX 4 D motif found in glycosyl transferases, were replaced by site-specific mutagenesis in order to evaluate the functional role of this motif in PhaG. The non-conserved Asp-182 was not required for enzyme activity, but is involved in substrate binding as indicated by a shift in substrate specificity toward longer medium chain length (R)-3-hydroxyacyl-CoAs by the PhaG mutants D182A and D182E, respectively (Table IV) . Both mutants still exhibited about 30% wild type activity suggesting that the HX 4 D motif found in most transacylases does not exert a specific function. The amino acid residue His-177 was required for enzyme activity, which was indicated by the loss of enzyme activity in the PhaG mutants H177A and H177K, respectively. Overall, this study suggests that this new family of transacylases, which catalyzes in vivo the transfer of an acyl moiety from holo-ACP to CoA, exerts a reaction mechanism similar to serine hydrolases and acyl transferases. 
